Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Fish and Richardson
Moodys
Farmers Insurance
AstraZeneca
Merck
Deloitte
Harvard Business School
Chubb
McKinsey

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,855,294

« Back to Dashboard

Summary for Patent: 4,855,294
Title: Method for reducing skin irritation associated with drug/penetration enhancer compositions
Abstract:A composition and method for reducing the skin irritation properties of a transdermal drug/enhancer composition which comprises incorporating into said composition, either prior to or at the time of application the skin, an effective amount of glycerin. When incorporated into the drug/enhancer composition prior to application to the skin the glycerin content will be between about 0.1 and 70 wt. %, preferably between about 1.0 and 50 wt. % and most preferably between about 5.0 and 20 wt. % of the composition.
Inventor(s): Patel; Dinesh C. (Murray, UT), Ebert; Charles D. (Salt Lake City, UT)
Assignee: TheraTech, Inc. (Salt Lake City, UT)
Application Number:07/240,688
Patent Claim Types:
see list of patent claims
Composition; Compound; Use;

Drugs Protected by US Patent 4,855,294

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,855,294

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 68910520 ➤ Subscribe
Canada 1332570 ➤ Subscribe
European Patent Office 0416137 ➤ Subscribe
Austria 96678 ➤ Subscribe
Spain 2053882 ➤ Subscribe
Japan H02115131 ➤ Subscribe
Japan 2953625 ➤ Subscribe
South Korea 0143916 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Moodys
Queensland Health
Federal Trade Commission
UBS
Daiichi Sankyo
Chinese Patent Office
Deloitte
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot